Micro-RNA Market By Tool 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Micro-RNA Market
Micro-RNA Market: By Tool (Microarrays, NGS, qRT-PCR, Northern Blotting, ISH), By End-User (Biotech Companies, Academic, Research Institutes) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast (2016-2021)
Report Code : HCR 0342
Updated Date: 11 March, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Micro-RNA Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Micro-RNA Market– Market Forces
   4.1. Drivers
      4.1.1. Development of molecular biology and genomic technologies
      4.1.2. Growing government’s healthcare funding
   4.2. Restraints
      4.2.1. Higher cost of research and development
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Micro-RNA Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Micro-RNA Market, By Tool
   6.1. Microarrays
   6.2. Next Generation Sequencing (NGS)
   6.3. Quantitative Real Time PCR (qRT-PCR)
   6.4. Northern Blotting
   6.5. In Situ Hybridization (ISH)
7. Micro-RNA Market, By End-Users
   7.1. Biotech Companies
   7.2. Academic
   7.3. Research institutes
8. Micro-RNA Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Micro-RNA – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Life Technologies Corporation
   10.2. Phalanx Biotech Group
   10.3. Thermo Fisher Scientific Inc.
   10.4. Merck & Co. Inc.
   10.5. CBC Comprehensive Biomarker Center GmbH
   10.6. F. Hoffman-La Roche
   10.7. GlaxoSmithKline
   10.8. Qiagen NV
   10.9. Roche Holding AG
   10.10. Novartis AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
MicroRNA, also known as miRNA, is a class of non-coding ribonucleic acid (RNA) which plays a vital role in the regulation of gene expression and also involved in RNA silencing. It is found in animals, plants and some viruses. Globally, development of efficient and advance technology, rise in the awareness among people regarding, increasing focus on research and development, growing government initiative across the globe, development of molecular biology and genomic technologies, and growing government’s healthcare funding are the prime growth drivers of global micro-RNA market. In addition, increase in adoption of micro-RNA in emerging economies such as China, India and others, will create new opportunities for global micro-RNA market. However, higher cost of the research and development, and lack of skilled professionals are the key restraints for global micro-RNA market.

 Micro-RNA Market

Geographically North America dominated global micro-RNA market, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, support from government, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing investments by the foreign countries in developing nations such as China, and India in this region. Among all the tools, Quantitative real time PCR (qRT-PCR) has the highest market share in global micro-RNA market due to higher prevalence of cancer patients.

This report identifies the global micro-RNA market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global micro-RNA market.

This report segments global micro-RNA market on the basis of tool, end-user, and regional market as follows:
  • Micro-RNA Market, By Tool: Microarrays, Next Generation Sequencing (NGS), Quantitative Real Time PCR (qRT-PCR), Northern Blotting, and In Situ Hybridization (ISH)
  • The report has focused study on micro-RNA market by basis of end-user such as: Biotech, Companies, Academic, and Research institutes
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the micro-RNA market. Some of the major companies’ profiles in detail are as follows:

  • Life Technologies Corporation
  • Phalanx Biotech Group
  • Thermo Fisher Scientific Inc.
  • Merck & Co. Inc.
  • CBC Comprehensive Biomarker Center GmbH
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports